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The obligatory role of follicle-stimulating hormone (FSH) in normal development and function of
ovarian antral follicles is well recognized, but its function in preantral growth is less clear. The
specific objective of this study was to investigate the response, in culture, to FSH of mouse preantral
follicles of increasing size, focusing particularly on growth rate and gene expression. Preantral
follicles were mechanically isolated from ovaries of C57BL/6 mice, 12 to 16 days postpartum, and
single follicles cultured for up to 96hours inmediumalone (n = 511) orwith recombinant human FSH
10 ng/mL (n = 546). Data were grouped according to initial follicle diameter in 6 strata ranging
from ,100 to.140 mm. Follicles of all sizes grew in the absence of FSH (P , 0.01, paired t test). All
follicles grew at a faster rate (P, 0.0001) in the presence of 10 ng/mL FSH but larger follicles showed
the greatest change in response to FSH. Even the smallest follicles expressed FSH receptormessenger
RNA (mRNA). FSH-induced growth was inhibited by KT5720, an inhibitor of protein kinase A (PKA),
implicating the PKA pathway in FSH-induced follicle growth. In response to FSH in vitro, FSH re-
ceptor mRNA (measured by quantitative polymerase chain reaction) was reduced (P, 0.01), as was
Amh (P , 0.01), whereas expression of StAR (P , 0.0001) and the steroidogenic enzymes Cyp11a1
(P, 0.01) and Cyp19 (P, 0.0001)was increased. These results showheterogeneous responses to FSH
according to initial follicle size, smaller follicles being less FSH dependent than larger preantral
follicles. These findings strongly suggest that FSH has a physiological role in preantral follicle growth
and function. (Endocrinology 158: 134–147, 2017)
F ollicle-stimulating hormone (FSH) is essential forantral follicle development in the mammalian ovary,
but its role in preantral growth is unclear. Depletion of
FSH in genetically hypogonadotropic mice (1, 2), fol-
lowing hypophysectomy (3, 4) or by pharmacological
suppression of FSH (5, 6) in mice or sheep, results in
depletion of antral follicles and arrest of follicle devel-
opment in the late preantral stages. Similarly, inmicewith
mutation of the FSH receptor gene (Fshr), follicle de-
velopment does not progress beyond the multilayered
preantral stage (2, 7, 8). In humans, the rarely reported
inactivating mutations of either the b subunit of FSH
(9–11) or the FSHR gene (10) are associated with a lack
of mature antral follicles, estrogen deficiency and
amenorrhea.
There is also plentiful evidence that FSH can influence
the development of preantral follicles both in vivo and
using in vitro culture of ovarian tissue explants or iso-
lated, multilayered preantral follicles. FSH administered
in vivo to mouse (1), rat (5) or sheep (6) promotes growth
and enhances survival of preantral follicles. Similar effects
have been noted when FSH is added to cultures of pre-
antral follicles derived from mouse (12–17), sheep (18),
and human (19). FSH binding sites have been demon-
strated in preantral follicles in ovaries of rodents (20) and
sheep (21), whereas FSHR gene expression has been shown
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in rodent (18, 22) and in human (23, 24) preantral follicles
from the primary stage onwards. It is clear, therefore, that
preantral follicles are capable of responding to FSH but the
question remains: how important is FSH in the physiology
of growth of preantral follicles?
In a key study of follicle development in the sheep,
Dufour et al. (4) quantified populations of preantral
follicles in the chronically hypophysectomized ewe and
found that the number of activated, small preantral follicles
was significantly reduced in the absence of FSH. A similar
effect of hypophysectomy on preantral follicle depletion
was noted in the mouse (3), and these 2 studies provide
evidence that FSHmight indeed have a physiological role in
maintaining the health and promoting the growth and
development of preantral follicles. Despite this intriguing
insight into the role of FSH in promoting follicle activation
and growth, very little is knownabout the dynamics of FSH
action in preantral follicles, particularly with regard to the
relationship between follicle size and responsiveness to
FSH. Further, there are fewdata regarding the effect of FSH
on gene expression in small preantral follicles. The specific
objective of this study was to investigate the response to
FSH of mouse preantral follicles, in culture, over a range of
follicle diameters, with respect to effects on rates of growth,
(including effects on cell proliferation and markers of
apoptosis) and on gene expression.
Materials and Methods
Animals and tissue collection
Whole ovaries were collected from female C57BL/6 mice
(Harlan Olac Ltd, Bicester, Oxon, UK) aged between 12 and
21 days postpartum (day of birth = 0 days postpartum), as
previously described (17).Mice were housed in accordance with
the Animals (Scientific Procedures) Act of 1986 and associated
Codes of Practice. Briefly, ovaries were dissected in Liebovitz’s
L-15 medium (Gibco, ThermoFisher Scientific, Paisley, UK)
supplemented with 1% [weight-to-volume (w/v)] bovine serum
albumin (BSA; Sigma, Sigma-Aldrich Ltd, Poole, Dorset, UK).
Day 12 and day 21 ovaries were fixed immediately in 10%
neutral buffered formalin (Sigma), dehydrated in a graded series
of ethanol, embedded in paraffin, and serially sectioned (5 mm)
for morphological analysis of follicle size and developmental
stage according to previous classifications (25). Briefly, follicles
with a single layer of flattened pregranulosa cells were termed
primordial; those with a mixture of cuboidal and flattened
granulosa cells (GCs), transitional; a single layer of entirely
cuboidal GCs, primary; the onset of a second layer of GCs,
primary plus; a complete second layer, secondary; and the onset
of a third layer, secondary plus. Follicles withmore than 3 layers
of GCs were termed multilayered. Two sections each from
ovaries from day 12 (n = 4) and day 21 (n = 4) pups were
analyzed. All follicles containing a sharply demarcated oocyte
nuclear membrane were measured. Follicle diameter (as defined
by the basal lamina surrounding the GCs) was calculated from
the mean of 2 perpendicular measurements using the image-
analysis program Lucia (Nikon UK). These measurements were
used to estimate the stage of development of isolated follicles.
Isolation and culture of mouse preantral follicles
Preantral follicles were mechanically isolated from day 14 to
17 ovaries using 29-gauge insulin needles or acupuncture needles
as previously described (17, 26). Follicles were placed in 96 well
plates (one ovary per plate) containing a-minimal essential me-
dium (Invitrogen) supplemented with 0.1% (w/v) BSA, 75 mg/mL
penicillin, 100 mg/mL streptomycin sulfate, and ITS (5 mg/mL
insulin, 5 mg/mL transferrin and 5 ng/mL sodium selenite, Sigma).
A single follicle was placed in each well containing 100 mL me-
dium, supplemented with phosphate-buffered saline vehicle alone
or a specified concentration of recombinant human FSH (rhFSH;
National Hormone and Peptide Program, National Institute of
Diabetes and Digestive and Kidney Diseases, Dr. A. F. Parlow,
Torrance, CA). Culturesweremaintained under humid conditions
at 37°C with 5% CO2 for 24, 72, or 96 hours.
For investigation of signaling via the PKA pathway, isolated
follicles were cultured as above in either 0.1 mm or 1 mm of the
PKA inhibitor KT5720 (Tocris Bioscience, Bristol, UK) with or
without 10 ng/mL rhFSH for 72 hours. Further studies were
carried out using 8-bromoadenosine 30,50-cyclic monophosphate
(8-br-cAMP, Sigma), a stable cAMP analog, at concentrations of
0.05, 0.5, and 1 mM in culture medium.
Measurement of follicles
Follicles were photographed at 24-hour intervals. Follicle
area was measured using ImageJ (1.45s; http://imagej.nih.gov/ij).
Images of follicles at consecutive time points, as well as
measurements, were imported into a custom-made database
(FileMaker Pro 11.v2; http://www.filemaker.com) to enable
easy inspection and analysis of follicles during development.
Follicles with a central spherical oocyte and intact layer of GCs
were selected for culture. At the end of culture (72 or 96 hours),
follicles were excluded from analysis if their oocyte became
misshapen or was extruded from the follicle or if the follicle
underwent atresia (darkened GCs). Follicles were analyzed
based on their diameter at the start of culture.
Immunofluorescence
At the end of culture, follicles were fixed in 10% neutral
buffered formalin (Sigma) andprocessed for immunofluorescence
analysis of GC apoptosis [terminal deoxynucleotidyltransferase-
mediated dUTP nick end labeling (TUNEL), cleaved caspase-3]
and proliferation (Ki67), as previously described (26). Antibodies
are listed in Table 1. Briefly, follicles were set in 2% (w/v) low
melting point agarose (Sigma), embedded in paraffin and sec-
tioned (5 mm). Sections were dewaxed and rehydrated before
boiling in citrate buffer (10 mM citric acid, pH 6.0). Potential
nonspecific interactionswere blockedwith 10%(w/v) goat serum
and 4% (w/v) BSA (Sigma). Sectionswere incubatedwith rat anti-
Ki67 (1:50; M7249, Dako) or rabbit anticleaved caspase-3
(1:200; 9664, Cell Signaling) overnight at 4°C. The latter were
subsequently exposed a 1:9 ratio of TUNEL enzyme:label
(Roche) for 60 minutes at 37°C after phosphate-buffered saline
washes. Sectionswere incubatedwith secondary antibodies (1:200;
Alexa488 or 555, Invitrogen) for 60minutes beforemountingwith
Prolong Gold medium containing 40,6-diamidino-2-phenylindole
(DAPI; Invitrogen). Images were recorded using a Leica inverted
SP-5 confocal microscope. The number of nuclei which were
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labeled just withDAPI, and those positive for themarker of interest
(Ki67, TUNEL or caspase), were counted in 1 section from each
follicle and the % of positive cells calculated.
Quantitative PCR
To examine expression of Fshr in follicles of different sizes,
freshly isolated preantral follicles were sorted into 4 size ranges
(75 to 90 mm, 91 to 110 mm, 111 to 130 mm, and .130 mm),
and samples containing 5 follicles were frozen in liquid nitrogen.
Total RNA was isolated from follicle samples using RNeasy
microcolumns, which include a DNase digestion step (Qiagen,
Crawley, West Sussex, UK). The entire RNA sample was con-
centrated using vacuum centrifugation and converted to com-
plementary DNA using random primers and SuperScript III
reverse transcription kit in accordance with supplied guidelines
(Life Technologies). Quantitative polymerase chain reaction
(qPCR) was performed on 384-well plates using an Applied
Biosystems 7900HT Fast instrument. For each reaction, com-
plementary DNA (1ml) was added to 400-nM primers (Table 2),
KAPA SYBR FASTmastermix with ROX (Labtech International)
and nuclease free water. Reactions were prepared in duplicate
and were subjected to an initial 95°C for 3 minutes, followed by
32 cycles of 95°C for 3 seconds, 60°C for 20 seconds, 72°C for
1 second, and 77°C for 10 seconds. A melting curve analysis of
products was performed to ensure consistent and specific am-
plification. Expression was normalized to the internal reference
Atp5b (PrimerDesign, Southampton, UK), which was stably
expressed across all samples. Fold changes relative to the 91- to
110-mm–size group (5 samples with consistent values) were cal-
culated using the 2-D-D-cycle threshold method (27).
To examine the effect of FSH on gene expression, follicles
were cultured for 24 hours in the presence and absence of
10ng/mL FSH, before pooling (n = 5) into the size ranges
described above. qPCR for genes of interest (Table 2) was
performed as described above, using cycle conditions of an
initial 95°C for 3 minutes, followed by 32 cycles of 95°C for
5 seconds, 57°C for 20 seconds, and 72°C for 3 seconds. Fold
changes relative to untreated follicles (0 ng/mL FSH) were
calculated using the 2-D-D-cycle threshold method.
In vitro knockdown of Fshr in preantral follicles
Size-matched preantral follicles were mechanically isolated
from mice aged 15 to 16 days as described above. Single follicles
were cultured in individualwells in 96well plateswith 1mmAccell
small interfering RNA (siRNA) designed to target exon 8 of the
mouseFshr transcript (GCGAUAACAAUAAUUUGGA;A-062874-
17; ThermoScientific). Control follicles were exposed to Accell
Nontargeting siRNA (D-001910-01; ThermoScientific) or Accell
RedNontargeting siRNA, containing a DY-547 label (D-001960-
01; ThermoScientific). After 24hours, 10ng/mL rhFSHwas added
to all groups, with the exception of an additional control group.
Follicles weremaintained in culture for another 96 hours andwere
photographeddailyusing lightmicroscopy for assessmentof growth
as described above. Fshrmessenger RNA (mRNA) expression was
reduced by 50% relative to nontargeting controls (data not shown).
Some of the follicles exposed to labeled siRNA were incubated in
5 mm DRAQ5 nuclear stain (Abcam; Cambridge, UK) for 10 min
before imaging in chamber slides usingaLeica invertedSP5 confocal
laser-scanningmicroscope (LeicaMicrosystems,Wetzlar,Germany)
to visualize penetration of siRNA into the follicle.
Statistics
Follicle area was measured for each follicle at the start of
culture (0 hours), and every 24 hours thereafter, up to 72 or
96 hours. Area was measured to increase accuracy of cumulative
growth curves, as the GCs of some follicles escaped from the basal
lamina after several days in culture, leading to an asymmetrical
Table 1. Antibody Table
Peptide/Protein
Target Antigen Sequence
Name of
Antibody
Manufacturer, Catalog
Number, or Name
of Source
Species Raised
in Monoclonal
or Polyclonal
Dilution
Used
Ki67 CD14, MKI67 Anti-Ki67 Dako UK Ltd, M7249 Rat, monoclonol 1 in 50
Cleaved
caspase-3
Large fragment (17/19 kDa)
resulting from cleavage
adjacent to Asp175
Anticleaved
caspase-3
Cell Signaling
Technology, 9664
Rabbit, monclonol 1 in 200
Table 2. Primers Used for PCR Assays
Gene Forward (50-30) Reverse (50-30)
Fshr ACAACTGTGCATTCAACGGAAC GACCTGGCCCTCAACTTCTT
Kitl1 GATTCCAGAGTCAGTGTCAC CCAGTATAAGGCTCCAAAAGCAA
Kitl2 CTTGTCAAAACCAAGGAGATCTGCG CTTTGCGGCTTTCCCTTTCTC
Ccnd2 CCCGACTCCTAAGACCCATC CCACTTCAGCTTACCCAACA
Cdkn1b CGGTGCCTTTAATTGGGTCT CTTCTTGGGCGTCTGCTC
Bmp15 GAGAACCGCACGATTGGAG AGTTCGTATGCTACCTGGTTTG
Ar ATTCCTGGATGGGACTGATG GCCCATCCACTGGAATAATG
Star AAGAACAACCCTTGAGCACCT CTCCCTGCTGGATGTAGGAC
Cyp19 ATCCACACTGTTGTGGGTGA ACTCGAGCCTGTGCATTCTT
Gja1 GTGGCCTGCTGAGAACCTAC GAGCGAGAGACACCAAGGAC
Amh GGGGCACACAGAACCTCT GCACCTTCTCTGCTTGGTTG
Gdf9 TCACCTCTACAATACCGTCCGG GAGCAAGTGTTCCATGGCAGTC
Cyp11a1 CTGGGCACTTTGGAGTCAGT AGGACGATTCGGTCTTTCTTC
Inha CTCCCAGGCTATCCTTTTCC TGGCCGGAATACATAAGTGA
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outline. For ease of comparison with previously published data,
follicle diameterwas calculated from follicle area [23 (√Area/p)].
Follicles were grouped in 6 size “bins” according to initial di-
ameter at 0 hours: ,100 mm, 100 to 109.99 mm, 110 to
119.99mm, 120 to 129.99mm, 130 to 139.99mm, and$140mm
in diameter. Relative area was calculated for each follicle between
0 hours (baseline) and 24 hours, 48 hours, 72 hours, and 96 hours
(area timex/area time0) and cumulative growth curves generated.
Data for each size bin were normally distributed with 1 exception
(110 to 119.99 mm + FSH). The overall growth of follicles in the
presence and absence of FSH, with or without 8-br-cAMP, was
compared using linear regression (Prism 6 for Mac OS X, version
6.0a; www.graphpad.com). The effect of FSH treatment on cu-
mulative growth of follicles was analyzed at each time point using
paired Student t test or analysis of variance (ANOVA) with ap-
propriate post hoc tests as described in figure legends (Prism 6). In
all cases, a probability value (P) less than 0.05 was considered
statistically significant.
Results
Classification of isolated preantral follicles and
response to FSH in culture
The follicles that were manually isolated from ovaries
of 15- to 17-day-old mice in these studies ranged between
70 and 150 mm in diameter. The follicles were cleanly
isolated, with only a few theca cells adherent to the basal
lamina [Fig. 1(A)]. Based on measurements of follicles
from histological sections taken on days 12 and 21 [Fig.
1(B) and 1(C)], follicles of 70 mm have at least 1 full layer
of cuboidal GCs, which is equivalent to a primary follicle
beginning to form a second layer [Fig. 1(D)]. Follicles
with diameters of 100 mm approximate to the secondary
stage with 2 complete layers of GCs; therefore, preantral
follicles with diameters greater than 100 mm will exhibit
more than 2 layers [Fig. 1(D)].
Figure 1. Relationship between follicle stage and diameter, and response to FSH. (A) Light micrograph of a freshly isolated follicle (;110 mm)
with 2 layers of GCs visible, surrounded by a basal lamina and occasional theca cells (arrow). Scale bar = 50 mm. (B, C) Histological sections of day
12 mouse ovary stained with hematoxylin and eosin. Scale bars = 50 mm. (B) Primary plus stage follicle with second layer of GCs forming, ;80 mm
in diameter. (C) Secondary plus stage follicle developing multiple layers of GCs, ;115 mm diameter. Dotted white line marks basal lamina. (D)
Follicle diameter of follicles at successive developmental stages in 12- and 21-days-postpartum mice. Follicles were measured in a formalin-fixed,
paraffin-embedded ovary. Values are mean 6 95% confidence interval. (E) Response of follicles to increasing concentrations of FSH. Relative follicle
areas (area at timex/area at time0, where tx = 24, 48, or 72 hours) were compared at each time point using 1-way ANOVA with a Tukey’s multiple
comparisons test. *P , 0.05; **P , 0.01; ***P , 0.001; ****P , 0.0001. Numbers in parentheses are numbers of follicles.
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Isolated follicles (70 to 150 mm) were assessed for their
ability to respond to increasing concentrations of FSH.When
all follicleswere considered independentof initial size, 1ng/mL
FSH promoted significant growth increase compared
with controls (0 ng/mL FSH) after 24 hours (P , 0.05) and
subsequent time points [Fig. 1(E)]. Follicles exposed to 10 or
100 ng/mL exhibited an even greater increase in size relative
to controls at all timepoints (P,0.0001). Follicles exposed to
10 ng/mL (equivalent to 67mIU/mL) grew at a similar rate to
follicles exposed to100ng/mL.This concentration (10ng/mL)
was therefore chosen as the minimum dose required to elicit a
maximal FSH-induced growth response in preantral follicles.
Fsh receptor (Fshr) expression in preantral follicles
Fshr mRNA expression was measureable by qPCR in
follicles of 75 to 90 mm in diameter (Fig. 2). Follicles of
this size are developing a second layer of GCs [Fig. 1(D)].
Levels did not change significantly between follicles of this
size range and those up to 130 mm. Expression signif-
icantly increased (P , 0.001) by approximately three-
fold in follicles .130 mm (.2 layers of GC) relative to
follicles ,130 mm (Fig. 2).
Size-dependent response of cultured preantral
follicles to FSH
Following 96 hours in vitro, in both the absence and
presence of 10 ng/mL FSH, follicles of all sizes were
significantly larger than they were at the start of culture
(paired t test; P, 0.01, Table 3). FSH stimulated growth
of follicles over 72 or 96 hours, including those with an
initial diameter smaller than 100 mm [Linear regression,
Fig. 3(A) and 3 (B)]. Follicles with an initial diameter
,130 mm exhibited a linear rate of growth over 96 hours
in the presence of FSH, whereas larger follicles (.130 mm)
began to increase in size in an exponential manner over
the same period [Fig. 3(C)]. In the absence of FSH,
follicles,130mmgrew significantly in the absence of FSH
in the first 24 hours, by comparison, follicles.130 did not
grow significantly during the same period (Table 3). This
suggested that smaller follicles were less responsive to FSH
than larger follicles, and this was examined in more detail.
Closer examination of follicle growth during the first
24 hours of culture showed that with increasing initial
follicle size, the ability of follicles to grow in the absence
of FSH decreased [Fig. 4]. In contrast, in the presence of
FSH, follicles of all sizes grew to a similar extent in the
Figure 2. Expression of Fshr in isolated preantral follicles.
Comparison of abundance of Fshr in isolated follicles of increasing
diameter (5 to 7 follicles per sample; number in bars = number of
samples). Transcripts were normalized to Atp5b, and fold changes
were calculated relative to expression in the 91- to 110-mm
diameter group. Values are mean fold changes 6 SEM. Fshr mRNA
was detectable in follicles in each size stratum. Relative levels of Fshr
in different sized follicles were compared using ANOVA with
a Tukey’s multiple comparisons test. ****P # 0.0001.
Table 3. More Sustained Growth in the Presence of FSH
Initial Diameter 0 to 24 24 to 48 48 to 72 72 to 96 0 to 96
– FSH
,100 ,0.0001 NS NS NS ,0.0001
100 to 110 ,0.0001 0.0008 0.02 NS ,0.0001
110 to 120 ,0.0001 0.004 0.0184 NS ,0.0001
120 to 130 ,0.0001 NS NS NS ,0.0001
130 to 140 NS NS NS NS ,0.0001
.140 NS NS NS NS ,0.0001
+ FSH (10 ng/mL)
,100 ,0.0001 ,0.0001 NS NS ,0.0001
100 to 110 ,0.0001 ,0.0001 ,0.0001 ,0.0001 ,0.0001
110 to 120 ,0.0001 ,0.0001 ,0.0001 ,0.0001 ,0.0001
120 to 130 ,0.0001 ,0.0001 ,0.0001 ,0.0001 ,0.0001
130 to 140 ,0.0001 ,0.0001 ,0.0001 ,0.0001 0.0001
.140 ,0.0001 0.0072 0.0048 NS 0.0052
Statistics ANOVA with a Tukey’s multiple comparisons test Paired t test 0 h vs 96 h
Follicles of all sizes were significantly larger at 96 hours than they were at the start of culture, with or without FSH, but growth was more sustained in the
presence of FSH.
Abbreviation: NS, not significant.
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first 24 hours, suggesting overall a greater dependency on
FSH with increasing follicle size.
Another notable finding was that, with increasing time
in culture, follicles exposed to FSH showed a wider distri-
bution of follicle diameter, demonstrating a heterogeneous
response to FSH [Fig. 5(A)]. In the absence of FSH, larger
follicles (.140 mm) showed little further growth [Fig.
5(A)(f)]. In contrast, in the presence of FSH, the growth
of follicles .120 mm diverged considerably, showing that
these follicles had marked heterogeneity in their response to
FSH [Fig. 5(A)(j–l)]. We went on to explore the response to
FSH of follicles spanning a wider size range, during the 48-
to 72-hour culture period. At 48 hours, follicles cultured in
the absence of FSH ranged in diameter from 83 to 186 mm,
and in the presence of FSH, from 83 to 214 mm. Over the
subsequent 24 hours, the growth of follicles of all diameters
did not differ significantly in the absence of FSH [Fig. 5(B)].
In contrast, in the presence of FSH, larger follicles grew
Figure 3. Effect of FSH (10 ng/mL) on in vitro growth of follicles of
different initial sizes. (A) Growth in vitro of preantral follicles of
increasing size. Values are means and standard deviation, lines are
regression slopes. Slopes were compared using linear regression. (B)
Morphology of the smallest (,100 mm) and largest (.140 mm)
preantral follicles cultured over 96 hours. (C) Growth curves (follicle
diameter) for follicles of increasing follicle size. Values are mean and
95% confidence interval. In the absence of FSH, follicles of
,120 mm reduced their growth after the first 24 hours, whereas
larger follicles maintained or accelerated their growth. In the
presence of FSH, follicles of ,100 mm showed slower growth after
Figure 3. (Continued). the first 24 hours in vitro. Follicles of
between 100 and 120 mm in diameter exhibited linear growth,
whereas those .120 mm at the outset exhibited accelerating growth.
Figure 4. Dependence of larger follicles on FSH. In the presence of
FSH follicles of all sizes grow to a similar extent (1-way ANOVA, not
significant [ns]). In the absence of FSH (pale bars), larger follicles do
not grow as much as smaller follicles during the first 24 hours of
culture, suggesting an increasing need for FSH as follicles get larger
(ANOVA, each size bin compared with ,100 mm diameter,
Dunnett’s multiple comparisons test—significantly less growth for
follicles .110 mm indicated by asterisks next to pale gray bars).
Relative follicle areas (area at time24 hours/area at time0) were
compared for each initial follicle diameter in the presence and
absence of FSH, using 1-way ANOVA with a Sidak’s multiple
comparisons test (6 comparisons). *P , 0.05; **P , 0.01; ***P ,
0.001; ****P , 0.0001. Values are means 6 95% confidence
interval. Dotted, vertical line indicates no change in follicle diameter
over the first 24 hours.
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significantlymore than smaller, showing that responsiveness
to FSH increased with size [Fig. 5(B)]. Importantly, with
FSH, a small proportion of follicles showed accelerated
growth [Fig. 5(C; arrowed) and 5(D)].
In line with the observation of growth and survival of
follicles in culture, even without FSH stimulation, we noted
that expression of Ki67 (a marker of cell proliferation) was
evident whether or not FSH was present, although there
Figure 5. Increased heterogeneity of follicle growth in the presence of FSH. (A) Growth curves (diameter) for individual follicles of increasing size in the
absence [A(a–f)] and presence [A(g–l)] of FSH. Follicles were cultured for 96 hours; numbers in parentheses are number of follicles. (B) Comparison of
growth of small (,125 mm), medium (125 to 150 mm), and large (.150 mm) follicles from 48 to 72 hours in the absence (n = 510) and presence (n =
546) of FSH. Values are median with 95% confidence interval. Numbers in the bars are number of follicles. Median values were compared using Kruskal-
Wallis with a Dunn’s multiple comparisons test. (C) Scattergram showing a subpopulation of larger follicles exhibiting accelerated growth in the presence
of FSH, between 48 and 72 hours (arrowed). (D) Growth of the individual follicle arrowed in (C), showing accelerated growth between 48 and 72 hours.
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were significantly more Ki67-positive nuclei in follicles cul-
tured with FSH (Fig. 6). A few apoptotic cells were present
with or without FSH, as evidenced by expression of
TUNEL and caspase-3 labeling. Follicles exposed to FSH
had a significantly higher proportion of active caspase-3
positive cells comparedwith controls (P, 0.001), whereas
the proportion of TUNEL positive cells was similar be-
tween the 2 groups [Fig. 6(E)].
Effect of reduced Fshr on preantral follicle growth
To assess the specific requirement for Fshr in FSH-
induced follicle growth, RNA-interference (siRNA) was
used to knockdown expression of the
receptor in isolated, cultured follicles.
The follicles in the 4 treatment groups
were of similar initial size (ANOVA,
not significant): control (no FSH),
median 116 mm (range 98 to 133 mm);
10ng/mL FSH, 114 mm (95 to 124);
siRNA, 113 mm (91 to 132); non-
targeting siRNA, 113 mm (95 to 129).
Preantral follicles cultured in the pres-
ence of a labeled (DY-547) nontargeting
siRNA revealed penetrance of siRNA
into the cytoplasm of many GCs [Fig.
7(A)]. Follicles preincubated for 24h in
siRNA targeting the Fshr transcript and
then exposed to FSH, grew at a similar
rate to control follicles that were not
exposed to either [Fig. 7(B) and 7(C)]. In
the presence of FSH, follicles exposed
to Fshr siRNAwere significantly smaller
than follicles exposed to nontargeting
siRNA (control) at every time point
[P, 0.05; Fig. 7(B) and 7(C)], showing
that FSHwas stimulating follicle growth
via Fshr.
Effect of FSH on gene expression in
cultured preantral follicles
Preantral follicles froma range of sizes
cultured for 24 hours in the presence
or absence of 10 ng/mL FSH were
assayed by qPCR to determine ex-
pression levels of a range of candidate
genes. FSH exposure was associated
with a substantial reduction in the level
of Fshr,Amh andGdf9 compared with
untreated controls (P , 0.05), whereas
no change in expression was found for
Ar, Kitl1, Kitl2, Inha, Bmp15, Gja1,
Cddkn1b and Ccnd2 (P . 0.05). By
comparison, transcript levels of the
steroidogenic enzymes Star, Cyp19a1, and Cyp11a1
were all elevated in follicles exposed to FSH [P , 0.01;
Fig. 8(A)].
When follicles were assayed according to initial size,
Gdf9 and Fshr were reduced in the larger group only
(.130 mm) when treated with FSH (P , 0.05), whereas
Amhwas reduced in follicles measuring 90 to 130mmonly.
Expression of Star andCyp19a1were increased in preantral
follicles exposed to FSH regardless of size (P , 0.05),
whereas considerable variability in was found in Cyp11a1
expression [P . 0.05; Fig. 8(B–H)].
Figure 6. Maintenance of follicle health in vitro in both the absence and presence of FSH.
(A and A0) Representative images of Ki67 immunolabeling (green) of follicles following
96 hours in culture in the (A) absence (–FSH) and (A0) presence (A +10 ng/mL FSH). DAPI labeled
nuclei, with no Ki67, are blue. (B and B0) Dual caspase (red) and TUNEL (green) labeling of
follicles cultured for 96 hours in the (B) absence (–FSH) and (B0) presence (+10 ng/mL FSH).
The percentage of positive nuclei in each treatment was quantified for (C) Ki67, (D) caspase,
and (E) TUNEL, and compared between control and +FSH using an unpaired t test. *P ,
0.05. Values are means and 95% confidence interval.
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FSH and the PKA pathway
To test whether FSH acts via the PKA pathway to
stimulate preantral follicle growth, follicles were cul-
tured in the presence and absence of FSH and the specific
PKA pathway inhibitor KT5720. The lowest concen-
tration of KT5720 (0.1 mm) had little effect on FSH-
stimulated follicle growth. However, 1 mm KT5720
significantly inhibited FSH-stimulated follicle growth to
levels similar to control [Fig. 9(A)], with no deleterious
effect on follicle health [Fig. 9(B)]. Follicle growth was
reduced below control levels in response to 1mmKT5720,
alone, again with no signs of follicle atresia [Fig. 9(B)],
suggesting inhibition of PKA signaling from other, en-
dogenous, stimuli.
Wewent on to explore how follicles responded to PKA
stimulation, using the cAMP analog 8-br-cAMP. The
lowest concentration of 8-br-cAMP alone (0.05 mM)
stimulated follicle growth to a similar extent to the effect
of 10 ng/mL FSH [Fig. 9(C) and 9(D)]. We therefore used
this concentration to compare consistent, stable cAMP
stimulation of PKApathway activity to stimulation by FSH
in follicles of various sizes [Fig. 9(E–G)]. Small follicles
(,110 mm initial diameter) grew more in 8-br-cAMP than
in FSH [Fig. 9(E)], while, conversely, large follicles
(.130 mm initial diameter) grew more in FSH than 8-br-
cAMP [Fig. 9(G)]. In medium-sized follicles (110 to
130mm) the growth trajectories were similar [Fig. 9(F)]. By
the end of the culture period [72 hours, Fig. 9(I)], the re-
sponse to 8-br-cAMP was similar in follicles of all sizes,
with follicle area increasing by around 1.4 times [Fig. 9(I)].
As expected, large follicles (.130 mm) grew more in the
presence of FSH than small follicles [,110 mm; P = 0.07,
Fig. 9(H)]. Intriguingly, the initial response (i.e. within
24 hours) to 8-br-cAMPdiffered depending on initial follicle
diameter. Smaller follicles (,110mm)weremore responsive
to 0.05 mM 8-br-cAMP, growing significantly more in the
first 24 hours than did larger follicles [.130 mm, Fig. 9(J)].
Discussion
In this systematic study of the effects of FSH on isolated
preantral follicles in culture, we have shown that follicle
growth is maintained throughout the 96 hours of culture
in the absence of FSH, but that addition of FSH causes
a substantial increase in the rate of growth. In the first
24 hours of culture, FSH does not significantly stimulate
growth of follicles smaller than 100 mm, suggesting that
follicles up to the secondary stage are not responsive to
FSH. However, FSH does stimulate these follicles over
a longer time period, most likely due to them reaching a
key threshold size. The observation that FSH stimulates
follicles larger than 100mmwithin 24 hours suggests that
this is the threshold size, and that the secondary stage of
follicle development (2 layers of GCs) marks the onset of
Figure 7. Knockdown of Fshr with siRNA inhibits follicle growth. (A) siRNA (green) is taken up from culture medium. Nuclei are red. (B) siRNA
targeted to Fshr significantly reduces follicle growth in the presence of FSH. Relative follicle areas (area at timex/area at time0) were compared
using 1-way ANOVA with a Tukey’s multiple comparisons test (6 comparisons). *P , 0.05; **P , 0.01; ***P , 0.001; ****P , 0.0001. Values
are means 6 95% confidence interval. Nontargeting siRNA did not significantly reduce follicle growth in the presence of FSH. (C) Follicles
cultured in the presence and absence of targeted and nontargeted siRNA remain healthy. Scale bars are 25 mm.
142 Hardy et al FSH Action in Mouse Prenatal Follicles Endocrinology, January 2017, 158(1):134–147
FSH responsiveness during preantral development. Fshr
gene expression is detectable, even in the smallest follicles,
but increases significantly at 130 mm (with 3 layers of
GCs), and as follicles further increase in size, they become
increasingly responsive to FSH, as marked by increased
growth. Indeed, the growth trajectory of a small subset
of follicles accelerates dramatically, leading to marked
heterogeneity of follicle size, which is not observed in the
absence of FSH. During late antral follicle development,
heterogeneity of follicle size and differing sensitivity to
FSH play a key role in selection of a dominant follicle.
Here, we have shown that this heterogeneity starts at the
multilayered preantral follicle stage, with follicles having
differing growth trajectories, likely due to varying levels
of Fshr expression.
Follicles larger than 140 mm in diameter show little
growth in the absence of FSH, suggesting that FSH is
becoming essential. Follicles were only cultured for a
maximum of 96 hours, so this does not preclude a slow
rate of growth over a longer time period. In addition,
the follicles were cleanly dissected, with minimal ad-
herent theca or stroma. These follicles therefore lacked
any growth factor stimulation from these cell compart-
ments, with the major growth factor involvement being
GC-specific AMH and KL and oocyte specific GDF9.
Figure 8. Fold change in expression of candidate genes in preantral follicles from 3 initial size groups (,90 mm, 90 to 130 mm, and .130 mm
in diameter) cultured in FSH (10 ng/mL). Fold changes (log2) for FSH treated follicles are presented relative to untreated follicles (value = 0). (A)
Overall fold change in follicles of all sizes. (B–G) Fold change in follicles where significant differences were detected in follicles of a particular size.
Gene expression in the absence and presence of 10 ng/mL FSH was compared for each gene using an unpaired t test. *P , 0.05; **P , 0.01;
***P , 0.001; ****P , 0.0001.
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Figure 9. Inhibition of the PKA pathway with KT5720 (KT, panel A) reduced follicle growth, whereas treatment with the cAMP analog, 8-br-
cAMP (C) stimulated follicle growth. (A) Response of preantral follicles to vehicle control medium, FSH (10 ng/mL), FSH + 0.1 mm KT5720, FSH +
1mM KT5720, and 0.1 and 1 mm KT5720 alone. FSH-stimulated growth was reversed with 1 mm KT5720. There was no significant difference in
the distribution of initial follicle size between treatments (Kruskal-Wallis). The relative area of follicles in different treatments (area at timex/area at
time0, where timex = 24, 48, or 72 hours) was compared at each time point using 1-way ANOVA with a Tukey’s multiple comparisons test. *P ,
0.05; **P , 0.01; ***P , 0.001; ****P , 0.0001. Values are means and 95% confidence interval. Numbers in parentheses are numbers of
follicles. (B) Growth of similarly sized follicles (between 110 and 120 mm) diameter, in the treatments described in (A), scale as in (D). Follicles in
all treatments remained healthy throughout the 72-hour culture period, as shown by morphology and absence of atresia (darkening of GCs). (C)
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Follicle growth was accompanied by protein expression
of the cell proliferation marker Ki67, which was increased
with exposure to FSH. Here, we confirm that FSH is not
essential for preantral growth, as evenafter a 96-hour culture
in the absence of FSH GC proliferation was observed, and
there was no increase in apoptosis. Surprisingly, in view of
thewell-documented actions of FSHas a survival factor (28),
the proportion of caspase-positive GCs was significantly
higher in the presence of FSH (Fig. 6). Similar stimulation of
both proliferation and apoptosis was observed previously in
follicles cultured in the presence of BMP15 and GDF9 to-
gether (26), suggesting an increase in cell turnover may be
induced as a self-regulatory mechanism to prevent excessive
follicle growth. The observed increase in apoptosis in the
presence of FSH may be due to inhibition of antiapoptotic
factors or stimulation of proapoptotic factors by FSH. The
former is a possibility, as expression of Gdf9 was down-
regulated by FSH in the current study, and GDF9 has been
shown to be antiapoptotic in large rat preantral follicles (29).
Indeed, in the same study, substantial apoptosis was noted in
follicles .200 mm in the presence of 10 ng/mL FSH alone
(the same concentration as in our study).
Total inhibition of FSH-stimulated follicle growth by
the PKA inhibitor KT5720 (1 mm) strongly suggests that
FSH action in preantral follicles is predominantly via the
PKA pathway. The reduction in follicle growth to below
control levels by 1 mm KT5720 alone implies that there
are other endogenous factors stimulating follicle growth
that act via the same pathway. On microscopy, the ab-
sence of darkening of GC and oocyte, as well as main-
tenance of smooth spherical shape of both oocyte and
follicle in the presence of inhibitor (which was used at a
10-fold lower concentration than that generally used in
other studies), indicate that the decreased growth was
very unlikely to be due to toxicity. We went on to explore
whether use of a cell permeable, phosphodiesterase re-
sistant, stable cAMP analog could recapitulate FSH ac-
tion. Incubation of follicles in both FSH and 8-br-cAMP
resulted in greater growth than FSH alone, whereas in-
cubation of follicles in increasing concentrations of 8-br-
cAMP alone resulted in increased growth in a dose
response manner. The lowest concentration of 8-br-cAMP
used (0.05mM)had a similar stimulatory effect to 10 ng/mL
FSH, so we went on to compare follicle growth stimulated
by FSH (acting via Fshr) to growth that was constantly and
directly stimulated by 8-br-cAMP. Interestingly, 8-br-cAMP
had a greater effect than FSH in small follicles, but was less
stimulatory than FSH in large follicles, strongly supporting
the evidence that Fshr, and hence PKA signaling, increases
with follicle size. Closer analysis of the effect of 8-br-cAMP
on follicles after 24 hours of exposure showed that follicles
of different sizes had varying responses to 8-br-cAMP. Small
follicles (,110 mm diameter) grew relatively more than
larger follicles (.130mm) in the presence of 8-br-cAMP.The
mechanisms underlying this are unclear, but raise the pos-
sibility of other, endogenous factors that contribute to follicle
growth via the PKA pathway. Involvement of the PKA
pathway in FSH-stimulated growth and differentiation has
previously been demonstrated in GCs from antral follicles
(30) but not, to our knowledge, in isolated preantral follicles.
In this study, we chose a single dose of FSH (10 ng/mL)
that we had previously shown to be effective in inducing
optimal follicle growth (17). Kreeger et al. (15) examined
dose-related effects of FSH on preantral follicles in a 3-
dimensional, alginate-based culture system, but in that
study, small and large follicles were grouped together and
thus, the influence of initial follicle size on the responsiveness
toFSHwasnot explored.Theydid, however, report that these
follicles were steroidogenically active, producing both pro-
gesterone and estradiol that could be detected in the culture
medium (15). Our data on gene expression of Cyp11a1,
Cyp19a1, and Star are consistent with their findings.
Previous reports of FSH-induced gene expression have
been largely confined to studies of antral follicles or mature
GCs (30–33). Roy and Greenwald (12) showed, 20 years
ago, that FSH induced DNA synthesis in preantral follicles.
Skory et al. (34) undertook an extensivemicroarray analysis
of gene expression in large (150 to 180 mm) preantral
follicles, followed by qPCR of key genes, but all follicles
were cultured in the presence of FSH and the focus here was
on the effects of time in culture on gene expression rather
than the action of FSH or the impact of follicle size. Fatehi
et al. (35) studied growth factor gene expression in mouse
preantral follicles in relation to the effects of vitrification
but, once again, neither the effects of follicle size nor FSHon
gene expression were considered. As mentioned above, our
finding of FSH-induced expression of Cyp11a1, Cyp19a1,
and Star reflect previous observations regarding steroido-
genic capacity of preantral follicles.However, it is intriguing
that, in our studies, we were able to show that even the
smallest follicles that were cultured showed FSH-dependent
expression of genes encoding key steroidogenic enzymes.
Our finding that FSH treatment was associated with
suppression of Amh gene expression in preantral follicles
Figure 9. (Continued). Response of preantral follicles to control medium (vehicle alone), FSH (10 ng/mL), FSH + 0.5 mM 8-bromo-cAMP, and
0.05, 0.5 and 1 mM 8-bromo-cAMP alone. Statistical analysis, values, error bars, numbers in parentheses and P values as in (A). (D) Growth of
similarly sized follicles (between 110 and 120 mm) diameter, in the treatments described in (C). Scale bar = 100 mm. Follicles remained healthy in
all treatments. (E–J) Response of follicles of different sizes to 0.05 mM 8-bromo-cAMP and 10 ng/mL FSH. 8-bromo-cAMP (0.05 mM) stimulated
follicle growth to a similar extent to 10 ng/mL FSH, and therefore was used as a positive control for PKA pathway activity.
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was intriguing. In situ hybridization studies have shown
that expression of AMH RNA in rat ovary is highest in
large preantral and small antral follicles and negligible in
large antral follicles (36, 37). It may be that as FSH sim-
ulates follicle growth, follicles are more rapidly reaching
a stage where AMH levels are coincidentally decreasing.
Furthermore, during FSH induction of ovulation, rising
serum levels of FSH are associated with declining con-
centrations of AMH. Interestingly, we observed an in-
hibitory effect of FSH on expression ofGdf9,whichwas in
contrast to our previous findings (no effect) (17). However,
this actionmayhavebeenmasked in that study by grouping
together preantral follicles of different sizes. In the current
study, the inhibitionofGdf9 expressionwasonly substantial
in follicles .130 mm, at the time when Fshr expression is
significantly upregulated. FSH-induced downregulation of
Fshr is, however, a well-recognized phenomenon (38, 39).
In conclusion, preantral follicles acquire FSH re-
ceptors and are responsive to FSH stimulation in terms
of growth and gene expression. There is marked het-
erogeneity of response, according to the initial follicle
diameter. Thus, although (as demonstrated in this study)
follicles can progress through the preantral stages without
FSH, our data confirm the notion of FSH responsiveness
in preantral follicles and support the concept of a physi-
ological role for FSH in preantral follicle growth and
function.
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